Literature DB >> 559355

Ocular manifestations of sickle hemoglobinopathies.

K C Nagpal, M F Goldberg, M F Rabb.   

Abstract

The ocular manifestations of sickle cell hemoglobinopathies, while often not severe enough to affect vision, may develop in proliferative stages, resulting in arteriolar-venular anastomoses, neovascular proliferations, vitreous hemorrhage and retinal detachment. The authors review the historical, biochemical, and geographic aspects of the disease, and provide detailed descriptions of findings in theconjunctiva, uvea and fundus, with particular emphasis on the retina. Pathogenesis, histopathologic and clinical appearance, and modes of treatment are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 559355     DOI: 10.1016/0039-6257(77)90042-x

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  11 in total

1.  Peripheral proliferative retinopathies.

Authors:  G C Brown; R H Brown; M M Brown
Journal:  Int Ophthalmol       Date:  1987-10       Impact factor: 2.031

2.  Spontaneous peripheral chorioretinal neovascularisation in association with sickle cell anaemia.

Authors:  J C Liang; L M Jampol
Journal:  Br J Ophthalmol       Date:  1983-02       Impact factor: 4.638

3.  A physical approach to model occlusions in the retinal microvasculature.

Authors:  O Fleck; T Savin
Journal:  Eye (Lond)       Date:  2018-01-12       Impact factor: 3.775

4.  Central macular splaying and outer retinal thinning in asymptomatic sickle cell patients by spectral-domain optical coherence tomography.

Authors:  Quan V Hoang; Felix Y Chau; Mahnaz Shahidi; Jennifer I Lim
Journal:  Am J Ophthalmol       Date:  2011-03-31       Impact factor: 5.258

5.  Conjunctival microvascular haemodynamics in sickle cell retinopathy.

Authors:  Ali Kord Valeshabad; Justin Wanek; Ruth Zelkha; Jennifer I Lim; Nicole Camardo; Bruce Gaynes; Mahnaz Shahidi
Journal:  Acta Ophthalmol       Date:  2014-11-27       Impact factor: 3.761

6.  Quantification of macular ischaemia in sickle cell retinopathy.

Authors:  C M Lee; H C Charles; R T Smith; N S Peachey; J G Cunha-Vaz; M F Goldberg
Journal:  Br J Ophthalmol       Date:  1987-07       Impact factor: 4.638

Review 7.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

8.  The ocular manifestations of sickle-cell disease: a prevalence and natural history study.

Authors:  J G Clarkson
Journal:  Trans Am Ophthalmol Soc       Date:  1992

9.  Retinal Oxygen Delivery and Metabolism in Healthy and Sickle Cell Retinopathy Subjects.

Authors:  Mahnaz Shahidi; Anthony E Felder; Ou Tan; Norman P Blair; David Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-04-01       Impact factor: 4.799

10.  Retinal thickness measurements in sickle cell patients with HbSS and HbSC genotype.

Authors:  Wei S Lim; Tejal Magan; Omar A Mahroo; Pirro G Hysi; Juliana Helou; Moin D Mohamed
Journal:  Can J Ophthalmol       Date:  2017-12-11       Impact factor: 1.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.